StemCures, a medical clinic in Ohio focused on stem cell therapy, will be establishing a manufacturing lab in Telangana with around $54 million investment and employment potential for around 150 people.
The facility will focus on stem cell therapy and capitalise on the latest technology and expertise from the U.S. to manufacture quality and affordable stem cell products for treating various serious medical conditions, IT and Industries Minister K.T. Rama Rao’s office said on Wednesday after founder Sairam Atluri met him in Boston.
“Setting up an R&D facility was seamless... looking forward to expanding with the manufacturing plant,” Mr.Atluri said. Currently, StemCures is culminating R&D of the stem cell line at Aspire Bionest in University of Hyderabad and ready to embark on a phase 1 manufacturing lab.
